Alabama HB127 prohibits the Board of Pharmacy from disciplining pharmacists for off-label drug recommendations and allows over-the-counter sale of.

Alabama HB127 protects pharmacists from disciplinary action by the Board of Pharmacy for recommending or dispensing off-label drugs, provided the use has been adequately tested on humans and potential harm determined. Employers and pharmacy benefits managers are also prohibited from taking adverse action against pharmacists for such recommendations or prescriptions. Additionally, the bill allows over-the-counter sale of Ivermectin and Hydroxychloroquine without a prescription. The act becomes effective on October 1, 2026.

Alabama HB127 prohibits the Board of Pharmacy from disciplining pharmacists for off-label drug recommendations and allows over-the-counter sale of.

Alabama HB127 protects pharmacists from disciplinary action by the Board of Pharmacy for recommending or dispensing off-label drugs, provided the use has been adequately tested on humans and potential harm determined. Employers and pharmacy benefits managers are also prohibited from taking adverse action against pharmacists for such recommendations or prescriptions. Additionally, the bill allows over-the-counter sale of Ivermectin and Hydroxychloroquine without a prescription. The act becomes effective on October 1, 2026.